BlackRock Inc. raised its stake in Atrion Co. (NASDAQ:ATRI) by 6.5% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 99,503 shares of the medical instruments supplier’s stock after buying an additional 6,095 shares during the quarter. BlackRock Inc. owned about 5.38% of Atrion worth $59,642,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds also recently made changes to their positions in the company. Xact Kapitalforvaltning AB bought a new position in Atrion in the first quarter valued at approximately $248,000. Principal Financial Group Inc. acquired a new stake in shares of Atrion in the first quarter valued at approximately $249,000. Chevy Chase Trust Holdings Inc. acquired a new stake in shares of Atrion in the second quarter valued at approximately $300,000. Bank of Montreal Can acquired a new stake in shares of Atrion in the second quarter valued at approximately $362,000. Finally, Citadel Advisors LLC raised its holdings in shares of Atrion by 49.8% in the first quarter. Citadel Advisors LLC now owns 638 shares of the medical instruments supplier’s stock valued at $403,000 after purchasing an additional 212 shares during the last quarter. 61.11% of the stock is currently owned by hedge funds and other institutional investors.
Separately, BidaskClub downgraded shares of Atrion from a “buy” rating to a “hold” rating in a report on Tuesday, August 28th.
NASDAQ ATRI opened at $680.60 on Friday. Atrion Co. has a 12-month low of $516.85 and a 12-month high of $718.11. The company has a market capitalization of $1.29 billion, a PE ratio of 38.15 and a beta of 0.56.
Atrion (NASDAQ:ATRI) last posted its quarterly earnings data on Tuesday, August 7th. The medical instruments supplier reported $4.70 earnings per share (EPS) for the quarter. Atrion had a net margin of 22.57% and a return on equity of 17.99%. The company had revenue of $38.85 million for the quarter.
The company also recently announced a quarterly dividend, which was paid on Friday, September 28th. Investors of record on Friday, September 14th were issued a dividend of $1.35 per share. This represents a $5.40 dividend on an annualized basis and a yield of 0.79%. This is an increase from Atrion’s previous quarterly dividend of $1.20. The ex-dividend date was Thursday, September 13th.
Atrion Company Profile
Atrion Corporation develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications worldwide. Its fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments.
Recommended Story: What does earnings per share mean?
Want to see what other hedge funds are holding ATRI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Atrion Co. (NASDAQ:ATRI).
Receive News & Ratings for Atrion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Atrion and related companies with MarketBeat.com's FREE daily email newsletter.